A Pilot Trial of Stepwise Implementation of Virtual Reality Mindfulness and Accelerated Transcranial Magnetic Stimulation Treatments for Dysphoria in Neuropsychiatric Disorders

Table 3

Paired -tests of primary clinician and self-rated scales from VR visit 1 to the designated VR Endpoint across the entire sample.

Measure	Mean		Std. error mean difference	Mean difference			Sig. (2-tailed)
	VR visit 1	VR endpoint
PHQ-9	15.40	13.85	.5548	1.5500	2.794	19	.012
GAD-7	12.80	12.40	.8284	.4000	.483	19	.635
PCL-5	32.70	26.30	1.9282	6.4000	3.319	19	.004
PROMIS pain intensity	5.00	5.25	.2702	-.2500	-.925	19	.367
SF-36 emotional well-being	33.47	37.47	3.1936	-4.000	-1.253	18	.226
MADRS	28.80	26.55	1.2935	2.2500	1.740	19	.098
HAM-A	23.05	21.05	1.2031	2.0000	1.662	19	.113
CAPS-5	30.30	26.05	1.8033	4.2500	2.357	19	.029
PROMIS pain interference	12.55	12.15	.7588	.4000	.527	19	.604